|

Alzheimer's Disease Clinical Trials in Raleigh, NC

15 recruiting studies within 50 miles

Phase
Trial Phase Dist.
Late Onset Alzheimer's Disease—<1 mi
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's DiseasePhase 2<1 mi
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's DementiaPhase 2<1 mi
Effect of Acetylcholinesterase Inhibitors on Bone MetabolismPhase 221 mi
A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's DiseasePhase 121 mi
Preventing Alzheimer's With Cognitive TrainingPhase 321 mi
Olfactory BiopsiesN/A21 mi
ADRC Clinical Cohort (Alzheimer's Disease)—21 mi
A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)Phase 121 mi
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR VariantPhase 321 mi
Retinal Imaging in Neurodegenerative Disease—21 mi
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's DiseasePhase 225 mi
Connect-Home: Alzheimer's Disease and Related DementiasN/A25 mi
Improving PCP Advance Care Planning for People With ADRDN/A25 mi
Physical Activity and Community EmPOWERment ProjectN/A25 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.